Professor, Medicine, University of Miami School of Medicine
Nephrology
Dr. Warren L. Kupin, MD
|
|
Give Review
Warren L. Kupin, MD practices Nephrology. He attended Medical College of Wisconsin. Medical College of Wisconsin is ranked 54 in research and 62 in primary care medicine He received 1 awards: "Super Doctor". Warren L. Kupin, MD is a published doctor. He published 51 publications, including: 'Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.' Warren Kupin accepts Medicare.
Publications
- Pre-transplant CD4 count influences immune reconstitution and risk of infectious complications in HIV(+) Kidney allograft recipients.
- Lower tacrolimus trough levels are associated with subsequently higher Acute rejection risk during the first 12 months after kidney transplantation.
- Reciprocating living Kidney donor generosity: tax credits, health insurance and an outcomes registry.
- Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary Kidney transplant recipients.
- Single-centre study of 628 adult, primary Kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.
- Lack of clinical association and effect of peripheral WBC counts on immune cell function test in Kidney transplant recipients with T-cell depleting induction and stero...
- Disparities among Blacks, Hispanics, and Whites in time from starting dialysis to Kidney transplant waitlisting.
- Predisposing factors of diminished survival in simultaneous liver/Kidney transplantation.
- Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients.
- Cost-utility analysis of living-donor Kidney transplantation followed by pancreas transplantation versus simultaneous pancreas-Kidney transplantation.
- Prognostic factors and early resumption of cyclosporin A in Renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
- The hyperkalemia of renal Failure: pathophysiology, diagnosis and therapy.
- Steroid-free immunosuppression after Renal transplantation.
- Common fluid-electrolyte and acid-base problems in the intensive care unit: selected issues.
- Results of lower extremity amputations in patients with end-stage renal Disease.
- A practical approach to nephrolithiasis.
- Clinical and Renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.
- Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric Renal transplantation.
- Effect on Renal function of change from high to moderate protein intake in type I diabetic patients.
- Anti-HLA antibodies complicating infectious mononucleosis With thrombocytopenia and neutropenia.
- Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric Renal transplant recipients.
- Cyclosporine-induced Renal macroangiopathy.
- Allogeneic whole pancreas transplantation in insulin-dependent Diabetes mellitus.
- An overview of Renal transplantation at Henry Ford Hospital.
- Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized Renal transplant recipients.
- Randomized Trial of Dual Antibody Induction Therapy With Steroid Avoidance in Renal Transplantation.
- Machine perfusion following static cold storage preservation in Kidney transplantation: donor-matched pair analysis of the prognostic impact of longer pump time.
- Randomized Trial of Immunosuppressive Regimens in Renal Transplantation.
- Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in Kidney transplantation.
- Effect of Kidney transplantation on outcomes among patients with hepatitis C.
- Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary Renal transplantation with tacrolimus and steroid avoidance: four-year ...
- Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population.
- Favorable outcomes with machine perfusion and longer pump times in Kidney transplantation: a single-center, observational study.
- Recurrence of lupus nephritis after Kidney transplantation.
- BK virus nephropathy after simultaneous pancreas-Kidney transplantation.
- Stable Renal function after islet transplantation: importance of patient selection and aggressive clinical management.
- Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary Renal transplant recipients given tacrolimus and daclizumab/thymoglobul...
- Campath-1H induction therapy in African American and Hispanic first Renal transplant recipients: 3-year actuarial follow-up.
- A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in Renal transplantation at 24 months of follow-up.
- A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in Renal transplantation: three-year analysis.
- A randomized trial of three Renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
- The use of Campath-1H as induction therapy in Renal transplantation: preliminary results.
- Hypercoagulable state associated with Kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy.
- Cytomegalovirus prophylaxis with valganciclovir in Kidney, pancreas-Kidney, and pancreas transplantation.
- A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in Renal transplantation. II. Survi...
- A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in Renal transplantatio...
- Hemolytic uremic syndrome after multivisceral transplantation treated With intravenous immunoglobulin.
- The use of daclizumab as induction therapy in combination With tacrolimus and mycophenolate mofetil in recipients With previous transplants.
- The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first Renal transplant recipients.
- Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary Kidney transplant recipients.
Schools
Medical College of Wisconsin
Henry Ford Hospital
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Super Doctor
Education
-
Henry Ford Hospital - Wayne State University -
Medical College of Wisconsin
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1568408532 | |
| NPPES Provider LastName | KUPIN | |
| NPPES Provider FirstName | WARREN | |
| NPPES Provider ZIPCode | 331361011 | |
| NPPES Provider State | FL | |
| Specialty Description | Nephrology | |
| Total Claim Count | 6787.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 0.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568408532 |
| Last Name Of The Provider | KUPIN |
| First Name Of The Provider | WARREN |
| View All |
Similar Doctors
|
|
Dr. Adela D. Mattiazzi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farhan Abid, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Carlos Granja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hassan Ali, MD |
|
|
Dr. Jair Munoz Mendoza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasil Peev, MD |
|
|
Dr. Alexander A. Velar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arif Asif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Lawrence Bress |